Principal Financial Group’s Ionis Pharmaceuticals IONS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $527K | Buy |
7,019
+3,680
| +110% | +$290K | ﹤0.01% | 2018 |
|
|
2025
Q4 | $264K | Sell |
3,339
-1,446
| -30% | -$109K | ﹤0.01% | 2102 |
|
|
2025
Q3 | $313K | Sell |
4,785
-3,166
| -40% | -$155K | ﹤0.01% | 2117 |
|
|
2025
Q2 | $314K | Sell |
7,951
-2,496
| -24% | -$81.7K | ﹤0.01% | 2057 |
|
|
2025
Q1 | $315K | Sell |
10,447
-3,169
| -23% | -$104K | ﹤0.01% | 1983 |
|
|
2024
Q4 | $476K | Buy |
13,616
+504
| +4% | +$18.8K | ﹤0.01% | 1973 |
|
|
2024
Q3 | $525K | Sell |
13,112
-4,346
| -25% | -$202K | ﹤0.01% | 1942 |
|
|
2024
Q2 | $832K | Sell |
17,458
-12,366
| -41% | -$507K | ﹤0.01% | 1878 |
|
|
2024
Q1 | $1.29M | Sell |
29,824
-1,315
| -4% | -$62.7K | ﹤0.01% | 1838 |
|
|
2023
Q4 | $1.58M | Sell |
31,139
-3,512
| -10% | -$168K | ﹤0.01% | 1793 |
|
|
2023
Q3 | $1.57M | Buy |
34,651
+1,381
| +4% | +$57K | ﹤0.01% | 1795 |
|
|
2023
Q2 | $1.37M | Sell |
33,270
-1,396
| -4% | -$53.6K | ﹤0.01% | 1801 |
|
|
2023
Q1 | $1.24M | Sell |
34,666
-3,656
| -10% | -$137K | ﹤0.01% | 1829 |
|
|
2022
Q4 | $1.45M | Sell |
38,322
-21,947
| -36% | -$923K | ﹤0.01% | 1812 |
|
|
2022
Q3 | $2.67M | Sell |
60,269
-51,899
| -46% | -$2.19M | ﹤0.01% | 1669 |
|
|
2022
Q2 | $4.15M | Buy |
112,168
+81,957
| +271% | +$3.09M | ﹤0.01% | 1618 |
|
|
2022
Q1 | $1.12M | Sell |
30,211
-1,544
| -5% | -$50.5K | ﹤0.01% | 1954 |
|
|
2021
Q4 | $966K | Sell |
31,755
-10,930
| -26% | -$344K | ﹤0.01% | 1990 |
|
|
2021
Q3 | $1.43M | Sell |
42,685
-5,285
| -11% | -$199K | ﹤0.01% | 1929 |
|
|
2021
Q2 | $1.91M | Buy |
47,970
+3,559
| +8% | +$139K | ﹤0.01% | 1924 |
|
|
2021
Q1 | $2M | Buy |
44,411
+3,385
| +8% | +$189K | ﹤0.01% | 1854 |
|
|
2020
Q4 | $2.32M | Sell |
41,026
-1,733
| -4% | -$86.4K | ﹤0.01% | 1772 |
|
|
2020
Q3 | $2.03M | Sell |
42,759
-2,716
| -6% | -$151K | ﹤0.01% | 1735 |
|
|
2020
Q2 | $2.68M | Buy |
45,475
+8,773
| +24% | +$488K | ﹤0.01% | 1629 |
|
|
2020
Q1 | $1.74M | Buy |
36,702
+1,244
| +4% | +$69.3K | ﹤0.01% | 1633 |
|
|
2019
Q4 | $2.14M | Sell |
35,458
-465
| -1% | -$27.7K | ﹤0.01% | 1716 |
|
|
2019
Q3 | $2.15M | Sell |
35,923
-1,458
| -4% | -$95K | ﹤0.01% | 1707 |
|
|
2019
Q2 | $2.4M | Buy |
37,381
+928
| +3% | +$65.6K | ﹤0.01% | 1700 |
|
|
2019
Q1 | $2.96M | Buy |
36,453
+3,212
| +10% | +$207K | ﹤0.01% | 1670 |
|
|
2018
Q4 | $1.8M | Sell |
33,241
-3,667
| -10% | -$187K | ﹤0.01% | 1732 |
|
|
2018
Q3 | $1.9M | Buy |
36,908
+1,453
| +4% | +$68.3K | ﹤0.01% | 1764 |
|
|
2018
Q2 | $1.48M | Sell |
35,455
-2,822
| -7% | -$125K | ﹤0.01% | 1785 |
|
|
2018
Q1 | $1.69M | Buy |
38,277
+1,479
| +4% | +$75.1K | ﹤0.01% | 1765 |
|
|
2017
Q4 | $1.85M | Buy |
36,798
+19,754
| +116% | +$1.08M | ﹤0.01% | 1765 |
|
|
2017
Q3 | $864K | Sell |
17,044
-4,401
| -21% | -$231K | ﹤0.01% | 1848 |
|
|
2017
Q2 | $1.09M | Buy |
21,445
+1,012
| +5% | +$47.1K | ﹤0.01% | 1835 |
|
|
2017
Q1 | $821K | Sell |
20,433
-907
| -4% | -$40.7K | ﹤0.01% | 1840 |
|
|
2016
Q4 | $1.02M | Sell |
21,340
-3,911
| -15% | -$155K | ﹤0.01% | 1812 |
|
|
2016
Q3 | $925K | Buy |
25,251
+380
| +2% | +$11.9K | ﹤0.01% | 1787 |
|
|
2016
Q2 | $579K | Buy |
24,871
+2,609
| +12% | +$84.2K | ﹤0.01% | 1827 |
|
|
2016
Q1 | $902K | Buy |
22,262
+359
| +2% | +$14.6K | ﹤0.01% | 1744 |
|
|
2015
Q4 | $1.36M | Buy |
21,903
+8
| +0% | +$432 | ﹤0.01% | 1710 |
|
|
2015
Q3 | $885K | Buy |
21,895
+11,497
| +111% | +$595K | ﹤0.01% | 1788 |
|
|
2015
Q2 | $598K | Sell |
10,398
-11,393
| -52% | -$724K | ﹤0.01% | 1849 |
|
|
2015
Q1 | $1.39M | Sell |
21,791
-96
| -0.4% | -$6.51K | ﹤0.01% | 1716 |
|
|
2014
Q4 | $1.35M | Sell |
21,887
-94
| -0.4% | -$4.64K | ﹤0.01% | 1753 |
|
|
2014
Q3 | $854K | Sell |
21,981
-2,458
| -10% | -$87.1K | ﹤0.01% | 1782 |
|
|
2014
Q2 | $842K | Sell |
24,439
-10,614
| -30% | -$334K | ﹤0.01% | 1812 |
|
|
2014
Q1 | $1.51M | Sell |
35,053
-321
| -0.9% | -$15.6K | ﹤0.01% | 1714 |
|
|
2013
Q4 | $1.41M | Buy |
35,374
+44
| +0.1% | +$1.57K | ﹤0.01% | 1732 |
|
|
2013
Q3 | $1.33M | Sell |
35,330
-1,972
| -5% | -$58.9K | ﹤0.01% | 1711 |
|
|
2013
Q2 | $1M | Buy |
+37,302
| New | +$793K | ﹤0.01% | 1726 |
|
Other funds holding IONS
VPM
VCM
Principal Financial Group's IONS Position: Q1 2026 in Review
Principal Financial Group increased its Ionis Pharmaceuticals (IONS) stake by 110% in Q1 2026, buying an estimated $290K and bringing the position to 7,019 shares worth $527K. The position accounts for ﹤0.01% of the portfolio, ranked #2018.
Principal Financial Group first reported a position in IONS in Q2 2013 and has held it in 52 quarters since. The position peaked at $4.15M in Q2 2022. 493 funds tracked by Wall St. Rank hold IONS as of Q1 2026.
- Principal Financial Group held 7,019 shares of Ionis Pharmaceuticals worth $527K as of Q1 2026.
- Principal Financial Group bought 3,680 Ionis Pharmaceuticals shares in Q1 2026, an estimated $290K.
- Ionis Pharmaceuticals made up ﹤0.01% of Principal Financial Group's portfolio in Q1 2026, its #2018 holding.
- Principal Financial Group first reported a position in Ionis Pharmaceuticals in Q2 2013 and has held it in 52 quarters since.
- Principal Financial Group's Ionis Pharmaceuticals position peaked at $4.15M in Q2 2022.
- 493 funds tracked by Wall St. Rank held Ionis Pharmaceuticals as of Q1 2026.
Based on Principal Financial Group's 13F filing for Q1 2026, filed 4 May 2026.